Primary Open-Angle Glaucoma

Administration of Ginkgo biloba extract did not significantly improve IOP or other endpoints of interest among patients with glaucoma or healthy volunteers, according to a review published in PLoS One.

  Seonix Bio launched SightScore, a polygenic risk score testing service for primary open-angle glaucoma, in the United States, according to a press release.

Patients with primary open-angle glaucoma or ocular hypertension who received QLS-111 experienced lower IOP in two phase 2 trials, according to a press release from Qlaris Bio.

INDIANAPOLIS — Loss of sensitivity in the central visual field may be associated with lower vision-related quality of life, especially in the inferior nasal point, according to a presentation at Academy 2024.

Affecting more than 1 billion people worldwide, migraine is among the most common neurological diseases. During their lives, 43% of women and 18% of men develop migraine.

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.

BOSTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Matt Link, chief commercial officer of Sight Sciences, shares information on the company’s clinical trials.

BOSTON — Phacoemulsification plus minimally invasive glaucoma surgery improves quality of life and prevents visual field loss in patients with glaucoma, according to a speaker.

The American Optometric Association has released a new, evidence-based clinical practice guideline draft, “Care of the Patient with Primary Open-Angle Glaucoma,” which is available online for peer and public review through April 24.

Patients with genetic risk for different glaucoma subtypes had an associated risk for different visual field defects, according to a study.